Skip to content

13F-HR filed by Consonance Capital Management LP

Consonance Capital Management LP filed this 13F-HR for the quarter ended 2014-03-31, filed 2014-05-15, with 27 holding rows worth $672,141,000.

Accession
0001085146-14-001224
Filed
2014-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2014

A holdings report, 27 entries on the cover page, a total value of $672,141,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $672,141,000 with VALUE read as thousands by filing date, 13F file number 028-14924. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
UNITED THERAPEUTICS CORP DEL COM91307C102Stock669,690$62,971,000thousands by filing date
MYRIAD GENETICS INC62855J104COM1,744,150$59,632,000thousands by filing date
FURIEX PHARMACEUTICALS36106P101COM616,495$53,635,000thousands by filing date
ENANTA PHARMACEUTICALS INC29251M106COM1,254,459$50,166,000thousands by filing date
BIOSCRIP INC09069N108COM5,022,772$35,059,000thousands by filing date
AEGERION PHARMACEUTICALS INC00767E102COM758,970$35,049,000thousands by filing date
INSYS THERAPEUTICS INC45824V209COMMON STOCK802,387$33,243,000thousands by filing date
ORTHOFIX INTL N VN6748L102COM1,098,670$33,125,000thousands by filing date
ANACOR PHARMACEUTICALS INC032420101COM1,610,467$32,225,000thousands by filing date
TARO PHARMACEUTICAL INDS LTDM8737E108SHS275,232$30,551,000thousands by filing date
MASIMO CORP COM574795100Stock1,089,034$29,742,000thousands by filing date
OSIRIS THERAPEUTICS INC NEW68827R108COM2,055,024$26,982,000thousands by filing date
HYPERION THERAPEUTICS INC44915N101COM1,026,092$26,473,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM1,226,772$19,935,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM36,600$16,030,000thousands by filing date
WUXI PHARMATECH CAYMAN INC929352102SPONS ADR SHS430,889$15,883,000thousands by filing date
INFINITY PHARMACEUTICALS INC45665G303COM1,262,012$15,005,000thousands by filing date
FLAMEL TECHNOLOGIES-SP ADR338488109SPON1,047,576$14,038,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM200,600$13,896,000thousands by filing date
Galena Biopharma Inc363256108COM5,446,469$13,616,000thousands by filing date
DERMA SCIENCES INC249827502COM PAR $.01891,555$11,305,000thousands by filing date
OPHTHOTECH CORP683745103COM311,287$11,105,000thousands by filing date
HEALTHWAYS INC422245100COM594,098$10,183,000thousands by filing date
ANI PHARMACEUTICALS INC00182C103COM251,263$7,877,000thousands by filing date
PERNIX THERAPEUTICS HOLDINGS71426V108COM1,217,203$6,512,000thousands by filing date
AKORN INC009728106COM295,000$6,490,000thousands by filing date
LIPOSCIENCE INC53630M108COM443,052$1,413,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-14-001224this filing2014-05-15acceptance time not in the bulk data set